Silence Therapeutics (SLN) PT Lowered to $45 at Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst Michael Ulz lowered the price target on Silence Therapeutics (NASDAQ: SLN) to $45.00 (from $49.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
